This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- Advanced medical imaging combined with genomic analysis could help treat cancer patientson January 31, 2020 at 6:19 pm
Even the individual cancer cells within the tumor can vary. "(The) diverse cellular composition and cellular interactions have not been well characterized," according to the study. To better ...
- Hospital hired fingerprint experts to unmask whistleblower, report findson January 29, 2020 at 4:01 pm
West Suffolk hospital downgraded after catalogue of failings and staff bullying ...
- Microscaled proteogenomic methods for precision oncologyon January 27, 2020 at 2:15 am
Cancer proteogenomics promises new insights into cancer biology and treatment efficacy ... DNA samples were additionally processed for Fluidigm Fingerprint Checks. By genotyping a panel of highly ...
- ‘It isn’t a big deal and it saves lives’: Dundee mum-of-three who battled cervical cancer and sepsis urges women to get smear testson January 26, 2020 at 6:46 am
“Precancerous changes precede cervical cancer by 10-15 years. Regular smear tests pick up these changes and treatment ... An innocent man has been paid more than £100,000 by police after he was ...
- Coaches vs. Cancer: Lenox, Wahconah girls basketball wins highlight huge slate of Berkshire County gameson January 25, 2020 at 4:39 pm
Cancer tournament's second game, held at Hoosac Valley on Saturday ... Morgan Marauszwski (14 points) hit a pair of threes in the third to keep the offense flowing. Maria Gamberoni had her ...
- Newly discovered immune cell 'may treat all cancers'on January 22, 2020 at 1:13 pm
Of course, cancer isn't a monolithic illness. Breastcancer.org says that "every cancer is different," and "each cancer has its own genetic identity, or fingerprint, created by the DNA in its cells." ...
- Doctors fear immunotherapy could actually make cancer WORSEon January 18, 2020 at 2:12 pm
A similar picture is emerging for lung cancer. So far, good news for patients who fail to respond to conventional approaches; surgery, chemotherapy and radiotherapy. But immunotherapy is not a magic ...
- Scientists develop a new AI breast cancer diagnostic toolon December 3, 2019 at 3:37 am
The team of researchers from Lancaster University and Airedale NHS Foundation Trust are using a specialised chemical analytical technique called Raman Spectroscopy on biopsies to identify the ...
- Scientists develop a new AI breast cancer diagnostic toolon December 3, 2019 at 3:05 am
After identifying the chemical fingerprints of breast cancer cells, and observing how they change, the researchers used this information to train complex machine learning algorithms to identify ...
via Bing News